Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Funds / Life Sciences Partners V Cv

Life Sciences Partners V Cv

HarvestClosed to new capitalFundADV: Venture Capital FundLSP Advisory BvNetherlands
Amounts, each with its basis
Vintage
2016basis: form d first sale
Target
unknownnot announced
First close
unknownnever inferred from a Form D
Final close
unknownonly from an announcement or an LP disclosure
Announced size
unknown
Form D offering
$54.2Mwhat may be sold, not what was raised; file 021-265006, sworn by the adviser or filed under this vehicle
Form D sold
$54.2Mas of the filing of Jun 14, 2016, 28 investors
First sale
Jun 1, 2016
Reported GAV
$277Mon the Form ADV filed Mar 29, 2024; the fund's assets, never its size or dry powder
Owners (ADV)
89
Reported on ADV
Mar 30, 2023 to Mar 29, 2024
Fundraising evidence
Closed to new capital
Form D filed or amended 2016-06-14: the stated $54.2M offering reported fully sold (fr-1)
evidence dated Jun 14, 2016. A Form D offering is permission to sell, not a fund in market; an amount sold is never a close; an evergreen offering amended every year is not a raise.
Lifecycle
Harvest
vintage over 7 years, still reported
age years: 10first sale: 2016-06-01vintage year: $2,016adv gav as of: 2024-03-29vintage basis: form_d_first_saleform d sold usd: $54.2Mform d offering usd: $54.2Mform d latest filed at: 2016-06-14
The fund's own reporting through time
11 Form ADV filings
FiledTypeGross asset value OwnersMin. investmentAdviser-ownedAudit
Mar 30, 2015Venture Capital Fund$96.8M
20$303,5234%yes
Mar 30, 2016Venture Capital Fund$211M
62$303,5232%yes
Mar 29, 2017Venture Capital Fund$256M
90$263,4992%yes
Mar 29, 2018Venture Capital Fund$124M
90$263,4992%yes
Mar 29, 2019Venture Capital Fund$165M
90$263,4992%yes
Mar 31, 2020Venture Capital Fund$202M
90$202,1312%yes
Mar 30, 2021Venture Capital Fund$302M
90$111,7402%yes
Mar 30, 2022Venture Capital Fund$284M
90$111,7402%yes
Mar 22, 2023Venture Capital Fund$284M
90$111,7402%yes
Mar 30, 2023Venture Capital Fund$196M
89$111,7402%yes
Mar 29, 2024Venture Capital Fund$277M
89$111,7402%yes
Principals and agents
3 principals on Form D, 0 placement agents
Limited partners and their reported performance
0 public LP reports
No public LP has reported this vehicle. The LP tape is read from public pension disclosures (see Limited partners); a fund appears here only when an LP’s report names it.
Investments attributed to this vehicle
0
No investment attributed to this vehicle. The firm’s investments sit on the firm; a fund gets one only when a source names the vehicle.
Timeline
2 events
  1. Jun 14, 2016
    Life Sciences Partners V C.V. filed Form D: $54,171,552 sold of $54,171,552, Venture Capital Fund
  2. Mar 30, 2015
    Life Sciences Partners V Cv first reported on Form ADV by LSP Or Life Sciences Partners (Venture Capital Fund), GAV $96,848,226
Evidence
16 observations
Every observation on this vehicle